These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 30342538

  • 1. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
    Hartmann K, Schlombs K, Laible M, Gürtler C, Schmidt M, Sahin U, Lehr HA.
    Diagn Pathol; 2018 Oct 20; 13(1):83. PubMed ID: 30342538
    [Abstract] [Full Text] [Related]

  • 2. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
    Laible M, Schlombs K, Kaiser K, Veltrup E, Herlein S, Lakis S, Stöhr R, Eidt S, Hartmann A, Wirtz RM, Sahin U.
    BMC Cancer; 2016 Jul 07; 16():398. PubMed ID: 27389414
    [Abstract] [Full Text] [Related]

  • 3. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
    Varga Z, Lebeau A, Bu H, Hartmann A, Penault-Llorca F, Guerini-Rocco E, Schraml P, Symmans F, Stoehr R, Teng X, Turzynski A, von Wasielewski R, Gürtler C, Laible M, Schlombs K, Joensuu H, Keller T, Sinn P, Sahin U, Bartlett J, Viale G.
    Breast Cancer Res; 2017 May 11; 19(1):55. PubMed ID: 28490348
    [Abstract] [Full Text] [Related]

  • 4. Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer.
    Gupta S, Mani NR, Carvajal-Hausdorf DE, Bossuyt V, Ho K, Weidler J, Wong W, Rhees B, Bates M, Rimm DL.
    Lab Invest; 2018 Aug 11; 98(8):1076-1083. PubMed ID: 29858579
    [Abstract] [Full Text] [Related]

  • 5. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection.
    Tramm T, Hennig G, Kyndi M, Alsner J, Sørensen FB, Myhre S, Sørlie T, Overgaard J.
    Virchows Arch; 2013 Dec 11; 463(6):775-86. PubMed ID: 24100522
    [Abstract] [Full Text] [Related]

  • 6. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
    Wu NC, Wong W, Ho KE, Chu VC, Rizo A, Davenport S, Kelly D, Makar R, Jassem J, Duchnowska R, Biernat W, Radecka B, Fujita T, Klein JL, Stonecypher M, Ohta S, Juhl H, Weidler JM, Bates M, Press MF.
    Breast Cancer Res Treat; 2018 Nov 11; 172(2):327-338. PubMed ID: 30120700
    [Abstract] [Full Text] [Related]

  • 7. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP, Schneeweiss A, Keller M, Schlombs K, Laible M, Seitz J, Lakis S, Veltrup E, Altevogt P, Eidt S, Wirtz RM, Marmé F.
    BMC Cancer; 2017 Feb 13; 17(1):124. PubMed ID: 28193205
    [Abstract] [Full Text] [Related]

  • 8. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S, Wang HY, Kim S, Ahn S, Lee D, Cho Y, Park KH, Jung D, Kim SI, Lee H.
    Int J Clin Exp Pathol; 2014 Feb 13; 7(10):6752-9. PubMed ID: 25400755
    [Abstract] [Full Text] [Related]

  • 9. ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
    Breyer J, Wirtz RM, Laible M, Schlombs K, Erben P, Kriegmair MC, Stoehr R, Eidt S, Denzinger S, Burger M, Hartmann A, Otto W.
    Virchows Arch; 2016 Nov 13; 469(5):547-552. PubMed ID: 27514658
    [Abstract] [Full Text] [Related]

  • 10. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
    Chen L, Chen Y, Xie Z, Luo J, Wang Y, Zhou J, Huang L, Li H, Wang L, Liu P, Shu M, Zhang W, Ke Z.
    Breast Cancer Res Treat; 2022 Aug 13; 194(3):517-529. PubMed ID: 35789315
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
    Wang HY, Park S, Kim S, Ahn S, Lee D, Kim S, Jung D, Park KH, Lee H.
    Int J Clin Exp Pathol; 2014 Aug 13; 7(9):5792-800. PubMed ID: 25337220
    [Abstract] [Full Text] [Related]

  • 12. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
    Filipits M, Rudas M, Singer CF, Fitzal F, Bago-Horvath Z, Greil R, Balic M, Lax SF, Halper S, Hulla W, Wu NC, Liu X, Weidler J, Bates M, Hlauschek D, Gnant M, Dubsky P.
    ESMO Open; 2021 Aug 13; 6(4):100228. PubMed ID: 34371382
    [Abstract] [Full Text] [Related]

  • 13. Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.
    Pape-Zambito D, Jiang Z, Wu H, Devarajan K, Slater CM, Cai KQ, Patchefsky A, Daly MB, Chen X.
    PLoS One; 2014 Aug 13; 9(6):e100488. PubMed ID: 24978026
    [Abstract] [Full Text] [Related]

  • 14. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S, Bartsch H, Sotlar K, Petat-Dutter K, Bonin M, Kahlert S, Harbeck N, Vogel U, Seeger H, Fehm T, Neubauer HJ.
    BMC Med Genomics; 2018 Sep 20; 11(1):80. PubMed ID: 30236106
    [Abstract] [Full Text] [Related]

  • 15. Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
    Wirtz RM, Sihto H, Isola J, Heikkilä P, Kellokumpu-Lehtinen PL, Auvinen P, Turpeenniemi-Hujanen T, Jyrkkiö S, Lakis S, Schlombs K, Laible M, Weber S, Eidt S, Sahin U, Joensuu H.
    Breast Cancer Res Treat; 2016 Jun 20; 157(3):437-46. PubMed ID: 27220750
    [Abstract] [Full Text] [Related]

  • 16. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
    Pu T, Guo P, Qiu Y, Chen S, Yang L, Sun L, Ye F, Bu H.
    Int J Clin Exp Pathol; 2015 Jun 20; 8(9):10565-74. PubMed ID: 26617766
    [Abstract] [Full Text] [Related]

  • 17. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Yamamoto S, Ibusuki M, Yamamoto Y, Fu P, Fujiwara S, Murakami K, Iwase H.
    Breast Cancer; 2013 Jul 20; 20(3):262-70. PubMed ID: 22362219
    [Abstract] [Full Text] [Related]

  • 18. Concordance between ER, PR, Ki67, and HER2-low expression in breast cancer by MammaTyper RT-qPCR and immunohistochemistry: implications for the practising pathologist.
    Badr NM, Zaakouk M, Zhang Q, Kearns D, Kong A, Shaaban AM.
    Histopathology; 2024 Sep 20; 85(3):437-450. PubMed ID: 38651302
    [Abstract] [Full Text] [Related]

  • 19. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS, Hong Y, Valdez KE, Michaels W, Hook M, Smith WP, Chien J, Herschkowitz JI, Troester MA, Beck M, Inciardi M, Gatewood J, May L, Cusick T, McGinness M, Ricci L, Fan F, Tawfik O, Marks JR, Knapp JR, Yeh HW, Thomas P, Carrasco DR, Fields TA, Godwin AK, Behbod F.
    Breast Cancer Res; 2015 Sep 17; 17():128. PubMed ID: 26384318
    [Abstract] [Full Text] [Related]

  • 20. Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance.
    Viale G, Slaets L, de Snoo FA, Bogaerts J, Russo L, van't Veer L, Rutgers EJ, Piccart-Gebhart MJ, Stork-Sloots L, Dell'Orto P, Glas AM, Cardoso F.
    Breast Cancer Res Treat; 2016 Feb 17; 155(3):463-9. PubMed ID: 26820652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.